Winningham Rick Einsider trades
In SEC Form 4 filings, Winningham Rick E is listed as CHIEF EXECUTIVE OFFICER of Theravance Biopharma, Inc. (TBPH) and Director of Jazz Pharmaceuticals plc (JAZZ). Winningham Rick E reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 24.
Companies and roles
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-24
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D | 1,382,272 | not reported | not reported | 228,750 | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D | 151,875 | not reported | not reported | 76,875 | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D | 76,875 | not reported | not reported | not reported | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D | 23,400 | not reported | not reported | not reported | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D | 92,567 | not reported | not reported | not reported | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D · derivative | 515,000 | $10.24 | $5,273,600 | not reported | No | Form 4 |
| JAZZJazz Pharmaceuticals plc | Aug 31 | Sep 2 | F | 1,692 | $241.39 | $408,432 | 9,480 | No | Form 4 |
| JAZZJazz Pharmaceuticals plc | Aug 31 | Sep 2 | F | 14 | $244.64 | $3,425 | 9,466 | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Aug 20 | Aug 24 | F | 20,034 | $16.95 | $339,576 | 1,611,022 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.